Global Binge Eating Disorder Drug Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family history, biological factors, long-term dieting and psychological issues increase risk. Signs and symptoms include eating unusually large amounts of food, frequently eating alone, feeling that eating behavior is out of control and experiencing depression and anxiety. Treatment includes psychOthersapy, medications and behavioral weight-loss programs.
The global Binge Eating Disorder Drug market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Binge Eating Disorder Drug Industry Forecast” looks at past sales and reviews total world Binge Eating Disorder Drug sales in 2023, providing a comprehensive analysis by region and market sector of projected Binge Eating Disorder Drug sales for 2024 through 2030. With Binge Eating Disorder Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Binge Eating Disorder Drug industry.
This Insight Report provides a comprehensive analysis of the global Binge Eating Disorder Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Binge Eating Disorder Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Binge Eating Disorder Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Binge Eating Disorder Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Binge Eating Disorder Drug.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report presents a comprehensive overview, market shares, and growth opportunities of Binge Eating Disorder Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
What is the 10-year outlook for the global Binge Eating Disorder Drug market?
What factors are driving Binge Eating Disorder Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Binge Eating Disorder Drug market opportunities vary by end market size?
How does Binge Eating Disorder Drug break out type, application?
Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family history, biological factors, long-term dieting and psychological issues increase risk. Signs and symptoms include eating unusually large amounts of food, frequently eating alone, feeling that eating behavior is out of control and experiencing depression and anxiety. Treatment includes psychOthersapy, medications and behavioral weight-loss programs.
The global Binge Eating Disorder Drug market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Binge Eating Disorder Drug Industry Forecast” looks at past sales and reviews total world Binge Eating Disorder Drug sales in 2023, providing a comprehensive analysis by region and market sector of projected Binge Eating Disorder Drug sales for 2024 through 2030. With Binge Eating Disorder Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Binge Eating Disorder Drug industry.
This Insight Report provides a comprehensive analysis of the global Binge Eating Disorder Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Binge Eating Disorder Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Binge Eating Disorder Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Binge Eating Disorder Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Binge Eating Disorder Drug.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report presents a comprehensive overview, market shares, and growth opportunities of Binge Eating Disorder Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
- Antidepressants
- Anticonvulsants
- Anti-obesity Medications
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Chronos Therapeutics
- Heptares
- Novo Nordisk
- Omeros Corp
- Sunovion Pharmaceuticals
- Opiant Pharmaceuticals
What is the 10-year outlook for the global Binge Eating Disorder Drug market?
What factors are driving Binge Eating Disorder Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Binge Eating Disorder Drug market opportunities vary by end market size?
How does Binge Eating Disorder Drug break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Binge Eating Disorder Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Binge Eating Disorder Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Binge Eating Disorder Drug by Country/Region, 2019, 2023 & 2030
2.2 Binge Eating Disorder Drug Segment by Type
2.2.1 Antidepressants
2.2.2 Anticonvulsants
2.2.3 Anti-obesity Medications
2.3 Binge Eating Disorder Drug Sales by Type
2.3.1 Global Binge Eating Disorder Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Binge Eating Disorder Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Binge Eating Disorder Drug Sale Price by Type (2019-2024)
2.4 Binge Eating Disorder Drug Segment by Application
2.4.1 Retail Pharmacies
2.4.2 Hospital Pharmacies
2.4.3 Online Pharmacies
2.5 Binge Eating Disorder Drug Sales by Application
2.5.1 Global Binge Eating Disorder Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Binge Eating Disorder Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Binge Eating Disorder Drug Sale Price by Application (2019-2024)
3 GLOBAL BINGE EATING DISORDER DRUG BY COMPANY
3.1 Global Binge Eating Disorder Drug Breakdown Data by Company
3.1.1 Global Binge Eating Disorder Drug Annual Sales by Company (2019-2024)
3.1.2 Global Binge Eating Disorder Drug Sales Market Share by Company (2019-2024)
3.2 Global Binge Eating Disorder Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Binge Eating Disorder Drug Revenue by Company (2019-2024)
3.2.2 Global Binge Eating Disorder Drug Revenue Market Share by Company (2019-2024)
3.3 Global Binge Eating Disorder Drug Sale Price by Company
3.4 Key Manufacturers Binge Eating Disorder Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Binge Eating Disorder Drug Product Location Distribution
3.4.2 Players Binge Eating Disorder Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BINGE EATING DISORDER DRUG BY GEOGRAPHIC REGION
4.1 World Historic Binge Eating Disorder Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Binge Eating Disorder Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Binge Eating Disorder Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Binge Eating Disorder Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Binge Eating Disorder Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Binge Eating Disorder Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Binge Eating Disorder Drug Sales Growth
4.4 APAC Binge Eating Disorder Drug Sales Growth
4.5 Europe Binge Eating Disorder Drug Sales Growth
4.6 Middle East & Africa Binge Eating Disorder Drug Sales Growth
5 AMERICAS
5.1 Americas Binge Eating Disorder Drug Sales by Country
5.1.1 Americas Binge Eating Disorder Drug Sales by Country (2019-2024)
5.1.2 Americas Binge Eating Disorder Drug Revenue by Country (2019-2024)
5.2 Americas Binge Eating Disorder Drug Sales by Type
5.3 Americas Binge Eating Disorder Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Binge Eating Disorder Drug Sales by Region
6.1.1 APAC Binge Eating Disorder Drug Sales by Region (2019-2024)
6.1.2 APAC Binge Eating Disorder Drug Revenue by Region (2019-2024)
6.2 APAC Binge Eating Disorder Drug Sales by Type
6.3 APAC Binge Eating Disorder Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Binge Eating Disorder Drug by Country
7.1.1 Europe Binge Eating Disorder Drug Sales by Country (2019-2024)
7.1.2 Europe Binge Eating Disorder Drug Revenue by Country (2019-2024)
7.2 Europe Binge Eating Disorder Drug Sales by Type
7.3 Europe Binge Eating Disorder Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Binge Eating Disorder Drug by Country
8.1.1 Middle East & Africa Binge Eating Disorder Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Binge Eating Disorder Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Binge Eating Disorder Drug Sales by Type
8.3 Middle East & Africa Binge Eating Disorder Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Binge Eating Disorder Drug
10.3 Manufacturing Process Analysis of Binge Eating Disorder Drug
10.4 Industry Chain Structure of Binge Eating Disorder Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Binge Eating Disorder Drug Distributors
11.3 Binge Eating Disorder Drug Customer
12 WORLD FORECAST REVIEW FOR BINGE EATING DISORDER DRUG BY GEOGRAPHIC REGION
12.1 Global Binge Eating Disorder Drug Market Size Forecast by Region
12.1.1 Global Binge Eating Disorder Drug Forecast by Region (2025-2030)
12.1.2 Global Binge Eating Disorder Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Binge Eating Disorder Drug Forecast by Type
12.7 Global Binge Eating Disorder Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Binge Eating Disorder Drug Product Portfolios and Specifications
13.1.3 Roche Binge Eating Disorder Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Chronos Therapeutics
13.2.1 Chronos Therapeutics Company Information
13.2.2 Chronos Therapeutics Binge Eating Disorder Drug Product Portfolios and Specifications
13.2.3 Chronos Therapeutics Binge Eating Disorder Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Chronos Therapeutics Main Business Overview
13.2.5 Chronos Therapeutics Latest Developments
13.3 Heptares
13.3.1 Heptares Company Information
13.3.2 Heptares Binge Eating Disorder Drug Product Portfolios and Specifications
13.3.3 Heptares Binge Eating Disorder Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Heptares Main Business Overview
13.3.5 Heptares Latest Developments
13.4 Novo Nordisk
13.4.1 Novo Nordisk Company Information
13.4.2 Novo Nordisk Binge Eating Disorder Drug Product Portfolios and Specifications
13.4.3 Novo Nordisk Binge Eating Disorder Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Novo Nordisk Main Business Overview
13.4.5 Novo Nordisk Latest Developments
13.5 Omeros Corp
13.5.1 Omeros Corp Company Information
13.5.2 Omeros Corp Binge Eating Disorder Drug Product Portfolios and Specifications
13.5.3 Omeros Corp Binge Eating Disorder Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Omeros Corp Main Business Overview
13.5.5 Omeros Corp Latest Developments
13.6 Sunovion Pharmaceuticals
13.6.1 Sunovion Pharmaceuticals Company Information
13.6.2 Sunovion Pharmaceuticals Binge Eating Disorder Drug Product Portfolios and Specifications
13.6.3 Sunovion Pharmaceuticals Binge Eating Disorder Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Sunovion Pharmaceuticals Main Business Overview
13.6.5 Sunovion Pharmaceuticals Latest Developments
13.7 Opiant Pharmaceuticals
13.7.1 Opiant Pharmaceuticals Company Information
13.7.2 Opiant Pharmaceuticals Binge Eating Disorder Drug Product Portfolios and Specifications
13.7.3 Opiant Pharmaceuticals Binge Eating Disorder Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Opiant Pharmaceuticals Main Business Overview
13.7.5 Opiant Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Binge Eating Disorder Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Binge Eating Disorder Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Binge Eating Disorder Drug by Country/Region, 2019, 2023 & 2030
2.2 Binge Eating Disorder Drug Segment by Type
2.2.1 Antidepressants
2.2.2 Anticonvulsants
2.2.3 Anti-obesity Medications
2.3 Binge Eating Disorder Drug Sales by Type
2.3.1 Global Binge Eating Disorder Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Binge Eating Disorder Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Binge Eating Disorder Drug Sale Price by Type (2019-2024)
2.4 Binge Eating Disorder Drug Segment by Application
2.4.1 Retail Pharmacies
2.4.2 Hospital Pharmacies
2.4.3 Online Pharmacies
2.5 Binge Eating Disorder Drug Sales by Application
2.5.1 Global Binge Eating Disorder Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Binge Eating Disorder Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Binge Eating Disorder Drug Sale Price by Application (2019-2024)
3 GLOBAL BINGE EATING DISORDER DRUG BY COMPANY
3.1 Global Binge Eating Disorder Drug Breakdown Data by Company
3.1.1 Global Binge Eating Disorder Drug Annual Sales by Company (2019-2024)
3.1.2 Global Binge Eating Disorder Drug Sales Market Share by Company (2019-2024)
3.2 Global Binge Eating Disorder Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Binge Eating Disorder Drug Revenue by Company (2019-2024)
3.2.2 Global Binge Eating Disorder Drug Revenue Market Share by Company (2019-2024)
3.3 Global Binge Eating Disorder Drug Sale Price by Company
3.4 Key Manufacturers Binge Eating Disorder Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Binge Eating Disorder Drug Product Location Distribution
3.4.2 Players Binge Eating Disorder Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BINGE EATING DISORDER DRUG BY GEOGRAPHIC REGION
4.1 World Historic Binge Eating Disorder Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Binge Eating Disorder Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Binge Eating Disorder Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Binge Eating Disorder Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Binge Eating Disorder Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Binge Eating Disorder Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Binge Eating Disorder Drug Sales Growth
4.4 APAC Binge Eating Disorder Drug Sales Growth
4.5 Europe Binge Eating Disorder Drug Sales Growth
4.6 Middle East & Africa Binge Eating Disorder Drug Sales Growth
5 AMERICAS
5.1 Americas Binge Eating Disorder Drug Sales by Country
5.1.1 Americas Binge Eating Disorder Drug Sales by Country (2019-2024)
5.1.2 Americas Binge Eating Disorder Drug Revenue by Country (2019-2024)
5.2 Americas Binge Eating Disorder Drug Sales by Type
5.3 Americas Binge Eating Disorder Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Binge Eating Disorder Drug Sales by Region
6.1.1 APAC Binge Eating Disorder Drug Sales by Region (2019-2024)
6.1.2 APAC Binge Eating Disorder Drug Revenue by Region (2019-2024)
6.2 APAC Binge Eating Disorder Drug Sales by Type
6.3 APAC Binge Eating Disorder Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Binge Eating Disorder Drug by Country
7.1.1 Europe Binge Eating Disorder Drug Sales by Country (2019-2024)
7.1.2 Europe Binge Eating Disorder Drug Revenue by Country (2019-2024)
7.2 Europe Binge Eating Disorder Drug Sales by Type
7.3 Europe Binge Eating Disorder Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Binge Eating Disorder Drug by Country
8.1.1 Middle East & Africa Binge Eating Disorder Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Binge Eating Disorder Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Binge Eating Disorder Drug Sales by Type
8.3 Middle East & Africa Binge Eating Disorder Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Binge Eating Disorder Drug
10.3 Manufacturing Process Analysis of Binge Eating Disorder Drug
10.4 Industry Chain Structure of Binge Eating Disorder Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Binge Eating Disorder Drug Distributors
11.3 Binge Eating Disorder Drug Customer
12 WORLD FORECAST REVIEW FOR BINGE EATING DISORDER DRUG BY GEOGRAPHIC REGION
12.1 Global Binge Eating Disorder Drug Market Size Forecast by Region
12.1.1 Global Binge Eating Disorder Drug Forecast by Region (2025-2030)
12.1.2 Global Binge Eating Disorder Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Binge Eating Disorder Drug Forecast by Type
12.7 Global Binge Eating Disorder Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Binge Eating Disorder Drug Product Portfolios and Specifications
13.1.3 Roche Binge Eating Disorder Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Chronos Therapeutics
13.2.1 Chronos Therapeutics Company Information
13.2.2 Chronos Therapeutics Binge Eating Disorder Drug Product Portfolios and Specifications
13.2.3 Chronos Therapeutics Binge Eating Disorder Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Chronos Therapeutics Main Business Overview
13.2.5 Chronos Therapeutics Latest Developments
13.3 Heptares
13.3.1 Heptares Company Information
13.3.2 Heptares Binge Eating Disorder Drug Product Portfolios and Specifications
13.3.3 Heptares Binge Eating Disorder Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Heptares Main Business Overview
13.3.5 Heptares Latest Developments
13.4 Novo Nordisk
13.4.1 Novo Nordisk Company Information
13.4.2 Novo Nordisk Binge Eating Disorder Drug Product Portfolios and Specifications
13.4.3 Novo Nordisk Binge Eating Disorder Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Novo Nordisk Main Business Overview
13.4.5 Novo Nordisk Latest Developments
13.5 Omeros Corp
13.5.1 Omeros Corp Company Information
13.5.2 Omeros Corp Binge Eating Disorder Drug Product Portfolios and Specifications
13.5.3 Omeros Corp Binge Eating Disorder Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Omeros Corp Main Business Overview
13.5.5 Omeros Corp Latest Developments
13.6 Sunovion Pharmaceuticals
13.6.1 Sunovion Pharmaceuticals Company Information
13.6.2 Sunovion Pharmaceuticals Binge Eating Disorder Drug Product Portfolios and Specifications
13.6.3 Sunovion Pharmaceuticals Binge Eating Disorder Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Sunovion Pharmaceuticals Main Business Overview
13.6.5 Sunovion Pharmaceuticals Latest Developments
13.7 Opiant Pharmaceuticals
13.7.1 Opiant Pharmaceuticals Company Information
13.7.2 Opiant Pharmaceuticals Binge Eating Disorder Drug Product Portfolios and Specifications
13.7.3 Opiant Pharmaceuticals Binge Eating Disorder Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Opiant Pharmaceuticals Main Business Overview
13.7.5 Opiant Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Binge Eating Disorder Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Binge Eating Disorder Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Antidepressants
Table 4. Major Players of Anticonvulsants
Table 5. Major Players of Anti-obesity Medications
Table 6. Global Binge Eating Disorder Drug Sales by Type (2019-2024) & (K Units)
Table 7. Global Binge Eating Disorder Drug Sales Market Share by Type (2019-2024)
Table 8. Global Binge Eating Disorder Drug Revenue by Type (2019-2024) & ($ million)
Table 9. Global Binge Eating Disorder Drug Revenue Market Share by Type (2019-2024)
Table 10. Global Binge Eating Disorder Drug Sale Price by Type (2019-2024) & (USD/Unit)
Table 11. Global Binge Eating Disorder Drug Sales by Application (2019-2024) & (K Units)
Table 12. Global Binge Eating Disorder Drug Sales Market Share by Application (2019-2024)
Table 13. Global Binge Eating Disorder Drug Revenue by Application (2019-2024)
Table 14. Global Binge Eating Disorder Drug Revenue Market Share by Application (2019-2024)
Table 15. Global Binge Eating Disorder Drug Sale Price by Application (2019-2024) & (USD/Unit)
Table 16. Global Binge Eating Disorder Drug Sales by Company (2019-2024) & (K Units)
Table 17. Global Binge Eating Disorder Drug Sales Market Share by Company (2019-2024)
Table 18. Global Binge Eating Disorder Drug Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Binge Eating Disorder Drug Revenue Market Share by Company (2019-2024)
Table 20. Global Binge Eating Disorder Drug Sale Price by Company (2019-2024) & (USD/Unit)
Table 21. Key Manufacturers Binge Eating Disorder Drug Producing Area Distribution and Sales Area
Table 22. Players Binge Eating Disorder Drug Products Offered
Table 23. Binge Eating Disorder Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Binge Eating Disorder Drug Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Binge Eating Disorder Drug Sales Market Share Geographic Region (2019-2024)
Table 28. Global Binge Eating Disorder Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Binge Eating Disorder Drug Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Binge Eating Disorder Drug Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Binge Eating Disorder Drug Sales Market Share by Country/Region (2019-2024)
Table 32. Global Binge Eating Disorder Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Binge Eating Disorder Drug Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Binge Eating Disorder Drug Sales by Country (2019-2024) & (K Units)
Table 35. Americas Binge Eating Disorder Drug Sales Market Share by Country (2019-2024)
Table 36. Americas Binge Eating Disorder Drug Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Binge Eating Disorder Drug Revenue Market Share by Country (2019-2024)
Table 38. Americas Binge Eating Disorder Drug Sales by Type (2019-2024) & (K Units)
Table 39. Americas Binge Eating Disorder Drug Sales by Application (2019-2024) & (K Units)
Table 40. APAC Binge Eating Disorder Drug Sales by Region (2019-2024) & (K Units)
Table 41. APAC Binge Eating Disorder Drug Sales Market Share by Region (2019-2024)
Table 42. APAC Binge Eating Disorder Drug Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Binge Eating Disorder Drug Revenue Market Share by Region (2019-2024)
Table 44. APAC Binge Eating Disorder Drug Sales by Type (2019-2024) & (K Units)
Table 45. APAC Binge Eating Disorder Drug Sales by Application (2019-2024) & (K Units)
Table 46. Europe Binge Eating Disorder Drug Sales by Country (2019-2024) & (K Units)
Table 47. Europe Binge Eating Disorder Drug Sales Market Share by Country (2019-2024)
Table 48. Europe Binge Eating Disorder Drug Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Binge Eating Disorder Drug Revenue Market Share by Country (2019-2024)
Table 50. Europe Binge Eating Disorder Drug Sales by Type (2019-2024) & (K Units)
Table 51. Europe Binge Eating Disorder Drug Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Binge Eating Disorder Drug Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Binge Eating Disorder Drug Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Binge Eating Disorder Drug Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Binge Eating Disorder Drug Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Binge Eating Disorder Drug Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Binge Eating Disorder Drug Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Binge Eating Disorder Drug
Table 59. Key Market Challenges & Risks of Binge Eating Disorder Drug
Table 60. Key Industry Trends of Binge Eating Disorder Drug
Table 61. Binge Eating Disorder Drug Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Binge Eating Disorder Drug Distributors List
Table 64. Binge Eating Disorder Drug Customer List
Table 65. Global Binge Eating Disorder Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Binge Eating Disorder Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Binge Eating Disorder Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Binge Eating Disorder Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Binge Eating Disorder Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Binge Eating Disorder Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Binge Eating Disorder Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Binge Eating Disorder Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Binge Eating Disorder Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Binge Eating Disorder Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Binge Eating Disorder Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Binge Eating Disorder Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Binge Eating Disorder Drug Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Binge Eating Disorder Drug Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Roche Basic Information, Binge Eating Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. Roche Binge Eating Disorder Drug Product Portfolios and Specifications
Table 81. Roche Binge Eating Disorder Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Roche Main Business
Table 83. Roche Latest Developments
Table 84. Chronos Therapeutics Basic Information, Binge Eating Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Chronos Therapeutics Binge Eating Disorder Drug Product Portfolios and Specifications
Table 86. Chronos Therapeutics Binge Eating Disorder Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Chronos Therapeutics Main Business
Table 88. Chronos Therapeutics Latest Developments
Table 89. Heptares Basic Information, Binge Eating Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Heptares Binge Eating Disorder Drug Product Portfolios and Specifications
Table 91. Heptares Binge Eating Disorder Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Heptares Main Business
Table 93. Heptares Latest Developments
Table 94. Novo Nordisk Basic Information, Binge Eating Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Novo Nordisk Binge Eating Disorder Drug Product Portfolios and Specifications
Table 96. Novo Nordisk Binge Eating Disorder Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Novo Nordisk Main Business
Table 98. Novo Nordisk Latest Developments
Table 99. Omeros Corp Basic Information, Binge Eating Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Omeros Corp Binge Eating Disorder Drug Product Portfolios and Specifications
Table 101. Omeros Corp Binge Eating Disorder Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Omeros Corp Main Business
Table 103. Omeros Corp Latest Developments
Table 104. Sunovion Pharmaceuticals Basic Information, Binge Eating Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Sunovion Pharmaceuticals Binge Eating Disorder Drug Product Portfolios and Specifications
Table 106. Sunovion Pharmaceuticals Binge Eating Disorder Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Sunovion Pharmaceuticals Main Business
Table 108. Sunovion Pharmaceuticals Latest Developments
Table 109. Opiant Pharmaceuticals Basic Information, Binge Eating Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Opiant Pharmaceuticals Binge Eating Disorder Drug Product Portfolios and Specifications
Table 111. Opiant Pharmaceuticals Binge Eating Disorder Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Opiant Pharmaceuticals Main Business
Table 113. Opiant Pharmaceuticals Latest Developments
Table 1. Binge Eating Disorder Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Binge Eating Disorder Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Antidepressants
Table 4. Major Players of Anticonvulsants
Table 5. Major Players of Anti-obesity Medications
Table 6. Global Binge Eating Disorder Drug Sales by Type (2019-2024) & (K Units)
Table 7. Global Binge Eating Disorder Drug Sales Market Share by Type (2019-2024)
Table 8. Global Binge Eating Disorder Drug Revenue by Type (2019-2024) & ($ million)
Table 9. Global Binge Eating Disorder Drug Revenue Market Share by Type (2019-2024)
Table 10. Global Binge Eating Disorder Drug Sale Price by Type (2019-2024) & (USD/Unit)
Table 11. Global Binge Eating Disorder Drug Sales by Application (2019-2024) & (K Units)
Table 12. Global Binge Eating Disorder Drug Sales Market Share by Application (2019-2024)
Table 13. Global Binge Eating Disorder Drug Revenue by Application (2019-2024)
Table 14. Global Binge Eating Disorder Drug Revenue Market Share by Application (2019-2024)
Table 15. Global Binge Eating Disorder Drug Sale Price by Application (2019-2024) & (USD/Unit)
Table 16. Global Binge Eating Disorder Drug Sales by Company (2019-2024) & (K Units)
Table 17. Global Binge Eating Disorder Drug Sales Market Share by Company (2019-2024)
Table 18. Global Binge Eating Disorder Drug Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Binge Eating Disorder Drug Revenue Market Share by Company (2019-2024)
Table 20. Global Binge Eating Disorder Drug Sale Price by Company (2019-2024) & (USD/Unit)
Table 21. Key Manufacturers Binge Eating Disorder Drug Producing Area Distribution and Sales Area
Table 22. Players Binge Eating Disorder Drug Products Offered
Table 23. Binge Eating Disorder Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Binge Eating Disorder Drug Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Binge Eating Disorder Drug Sales Market Share Geographic Region (2019-2024)
Table 28. Global Binge Eating Disorder Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Binge Eating Disorder Drug Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Binge Eating Disorder Drug Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Binge Eating Disorder Drug Sales Market Share by Country/Region (2019-2024)
Table 32. Global Binge Eating Disorder Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Binge Eating Disorder Drug Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Binge Eating Disorder Drug Sales by Country (2019-2024) & (K Units)
Table 35. Americas Binge Eating Disorder Drug Sales Market Share by Country (2019-2024)
Table 36. Americas Binge Eating Disorder Drug Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Binge Eating Disorder Drug Revenue Market Share by Country (2019-2024)
Table 38. Americas Binge Eating Disorder Drug Sales by Type (2019-2024) & (K Units)
Table 39. Americas Binge Eating Disorder Drug Sales by Application (2019-2024) & (K Units)
Table 40. APAC Binge Eating Disorder Drug Sales by Region (2019-2024) & (K Units)
Table 41. APAC Binge Eating Disorder Drug Sales Market Share by Region (2019-2024)
Table 42. APAC Binge Eating Disorder Drug Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Binge Eating Disorder Drug Revenue Market Share by Region (2019-2024)
Table 44. APAC Binge Eating Disorder Drug Sales by Type (2019-2024) & (K Units)
Table 45. APAC Binge Eating Disorder Drug Sales by Application (2019-2024) & (K Units)
Table 46. Europe Binge Eating Disorder Drug Sales by Country (2019-2024) & (K Units)
Table 47. Europe Binge Eating Disorder Drug Sales Market Share by Country (2019-2024)
Table 48. Europe Binge Eating Disorder Drug Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Binge Eating Disorder Drug Revenue Market Share by Country (2019-2024)
Table 50. Europe Binge Eating Disorder Drug Sales by Type (2019-2024) & (K Units)
Table 51. Europe Binge Eating Disorder Drug Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Binge Eating Disorder Drug Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Binge Eating Disorder Drug Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Binge Eating Disorder Drug Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Binge Eating Disorder Drug Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Binge Eating Disorder Drug Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Binge Eating Disorder Drug Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Binge Eating Disorder Drug
Table 59. Key Market Challenges & Risks of Binge Eating Disorder Drug
Table 60. Key Industry Trends of Binge Eating Disorder Drug
Table 61. Binge Eating Disorder Drug Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Binge Eating Disorder Drug Distributors List
Table 64. Binge Eating Disorder Drug Customer List
Table 65. Global Binge Eating Disorder Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Binge Eating Disorder Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Binge Eating Disorder Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Binge Eating Disorder Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Binge Eating Disorder Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Binge Eating Disorder Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Binge Eating Disorder Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Binge Eating Disorder Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Binge Eating Disorder Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Binge Eating Disorder Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Binge Eating Disorder Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Binge Eating Disorder Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Binge Eating Disorder Drug Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Binge Eating Disorder Drug Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Roche Basic Information, Binge Eating Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. Roche Binge Eating Disorder Drug Product Portfolios and Specifications
Table 81. Roche Binge Eating Disorder Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Roche Main Business
Table 83. Roche Latest Developments
Table 84. Chronos Therapeutics Basic Information, Binge Eating Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Chronos Therapeutics Binge Eating Disorder Drug Product Portfolios and Specifications
Table 86. Chronos Therapeutics Binge Eating Disorder Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Chronos Therapeutics Main Business
Table 88. Chronos Therapeutics Latest Developments
Table 89. Heptares Basic Information, Binge Eating Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Heptares Binge Eating Disorder Drug Product Portfolios and Specifications
Table 91. Heptares Binge Eating Disorder Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Heptares Main Business
Table 93. Heptares Latest Developments
Table 94. Novo Nordisk Basic Information, Binge Eating Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Novo Nordisk Binge Eating Disorder Drug Product Portfolios and Specifications
Table 96. Novo Nordisk Binge Eating Disorder Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Novo Nordisk Main Business
Table 98. Novo Nordisk Latest Developments
Table 99. Omeros Corp Basic Information, Binge Eating Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Omeros Corp Binge Eating Disorder Drug Product Portfolios and Specifications
Table 101. Omeros Corp Binge Eating Disorder Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Omeros Corp Main Business
Table 103. Omeros Corp Latest Developments
Table 104. Sunovion Pharmaceuticals Basic Information, Binge Eating Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Sunovion Pharmaceuticals Binge Eating Disorder Drug Product Portfolios and Specifications
Table 106. Sunovion Pharmaceuticals Binge Eating Disorder Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Sunovion Pharmaceuticals Main Business
Table 108. Sunovion Pharmaceuticals Latest Developments
Table 109. Opiant Pharmaceuticals Basic Information, Binge Eating Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Opiant Pharmaceuticals Binge Eating Disorder Drug Product Portfolios and Specifications
Table 111. Opiant Pharmaceuticals Binge Eating Disorder Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Opiant Pharmaceuticals Main Business
Table 113. Opiant Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Binge Eating Disorder Drug
Figure 2. Binge Eating Disorder Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Binge Eating Disorder Drug Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Binge Eating Disorder Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Binge Eating Disorder Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Antidepressants
Figure 10. Product Picture of Anticonvulsants
Figure 11. Product Picture of Anti-obesity Medications
Figure 12. Global Binge Eating Disorder Drug Sales Market Share by Type in 2023
Figure 13. Global Binge Eating Disorder Drug Revenue Market Share by Type (2019-2024)
Figure 14. Binge Eating Disorder Drug Consumed in Retail Pharmacies
Figure 15. Global Binge Eating Disorder Drug Market: Retail Pharmacies (2019-2024) & (K Units)
Figure 16. Binge Eating Disorder Drug Consumed in Hospital Pharmacies
Figure 17. Global Binge Eating Disorder Drug Market: Hospital Pharmacies (2019-2024) & (K Units)
Figure 18. Binge Eating Disorder Drug Consumed in Online Pharmacies
Figure 19. Global Binge Eating Disorder Drug Market: Online Pharmacies (2019-2024) & (K Units)
Figure 20. Global Binge Eating Disorder Drug Sales Market Share by Application (2023)
Figure 21. Global Binge Eating Disorder Drug Revenue Market Share by Application in 2023
Figure 22. Binge Eating Disorder Drug Sales Market by Company in 2023 (K Units)
Figure 23. Global Binge Eating Disorder Drug Sales Market Share by Company in 2023
Figure 24. Binge Eating Disorder Drug Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Binge Eating Disorder Drug Revenue Market Share by Company in 2023
Figure 26. Global Binge Eating Disorder Drug Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Binge Eating Disorder Drug Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Binge Eating Disorder Drug Sales 2019-2024 (K Units)
Figure 29. Americas Binge Eating Disorder Drug Revenue 2019-2024 ($ Millions)
Figure 30. APAC Binge Eating Disorder Drug Sales 2019-2024 (K Units)
Figure 31. APAC Binge Eating Disorder Drug Revenue 2019-2024 ($ Millions)
Figure 32. Europe Binge Eating Disorder Drug Sales 2019-2024 (K Units)
Figure 33. Europe Binge Eating Disorder Drug Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Binge Eating Disorder Drug Sales 2019-2024 (K Units)
Figure 35. Middle East & Africa Binge Eating Disorder Drug Revenue 2019-2024 ($ Millions)
Figure 36. Americas Binge Eating Disorder Drug Sales Market Share by Country in 2023
Figure 37. Americas Binge Eating Disorder Drug Revenue Market Share by Country in 2023
Figure 38. Americas Binge Eating Disorder Drug Sales Market Share by Type (2019-2024)
Figure 39. Americas Binge Eating Disorder Drug Sales Market Share by Application (2019-2024)
Figure 40. United States Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Binge Eating Disorder Drug Sales Market Share by Region in 2023
Figure 45. APAC Binge Eating Disorder Drug Revenue Market Share by Regions in 2023
Figure 46. APAC Binge Eating Disorder Drug Sales Market Share by Type (2019-2024)
Figure 47. APAC Binge Eating Disorder Drug Sales Market Share by Application (2019-2024)
Figure 48. China Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Binge Eating Disorder Drug Sales Market Share by Country in 2023
Figure 56. Europe Binge Eating Disorder Drug Revenue Market Share by Country in 2023
Figure 57. Europe Binge Eating Disorder Drug Sales Market Share by Type (2019-2024)
Figure 58. Europe Binge Eating Disorder Drug Sales Market Share by Application (2019-2024)
Figure 59. Germany Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Binge Eating Disorder Drug Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Binge Eating Disorder Drug Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Binge Eating Disorder Drug Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Binge Eating Disorder Drug Sales Market Share by Application (2019-2024)
Figure 68. Egypt Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Binge Eating Disorder Drug in 2023
Figure 74. Manufacturing Process Analysis of Binge Eating Disorder Drug
Figure 75. Industry Chain Structure of Binge Eating Disorder Drug
Figure 76. Channels of Distribution
Figure 77. Global Binge Eating Disorder Drug Sales Market Forecast by Region (2025-2030)
Figure 78. Global Binge Eating Disorder Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Binge Eating Disorder Drug Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Binge Eating Disorder Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Binge Eating Disorder Drug Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Binge Eating Disorder Drug Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Binge Eating Disorder Drug
Figure 2. Binge Eating Disorder Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Binge Eating Disorder Drug Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Binge Eating Disorder Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Binge Eating Disorder Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Antidepressants
Figure 10. Product Picture of Anticonvulsants
Figure 11. Product Picture of Anti-obesity Medications
Figure 12. Global Binge Eating Disorder Drug Sales Market Share by Type in 2023
Figure 13. Global Binge Eating Disorder Drug Revenue Market Share by Type (2019-2024)
Figure 14. Binge Eating Disorder Drug Consumed in Retail Pharmacies
Figure 15. Global Binge Eating Disorder Drug Market: Retail Pharmacies (2019-2024) & (K Units)
Figure 16. Binge Eating Disorder Drug Consumed in Hospital Pharmacies
Figure 17. Global Binge Eating Disorder Drug Market: Hospital Pharmacies (2019-2024) & (K Units)
Figure 18. Binge Eating Disorder Drug Consumed in Online Pharmacies
Figure 19. Global Binge Eating Disorder Drug Market: Online Pharmacies (2019-2024) & (K Units)
Figure 20. Global Binge Eating Disorder Drug Sales Market Share by Application (2023)
Figure 21. Global Binge Eating Disorder Drug Revenue Market Share by Application in 2023
Figure 22. Binge Eating Disorder Drug Sales Market by Company in 2023 (K Units)
Figure 23. Global Binge Eating Disorder Drug Sales Market Share by Company in 2023
Figure 24. Binge Eating Disorder Drug Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Binge Eating Disorder Drug Revenue Market Share by Company in 2023
Figure 26. Global Binge Eating Disorder Drug Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Binge Eating Disorder Drug Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Binge Eating Disorder Drug Sales 2019-2024 (K Units)
Figure 29. Americas Binge Eating Disorder Drug Revenue 2019-2024 ($ Millions)
Figure 30. APAC Binge Eating Disorder Drug Sales 2019-2024 (K Units)
Figure 31. APAC Binge Eating Disorder Drug Revenue 2019-2024 ($ Millions)
Figure 32. Europe Binge Eating Disorder Drug Sales 2019-2024 (K Units)
Figure 33. Europe Binge Eating Disorder Drug Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Binge Eating Disorder Drug Sales 2019-2024 (K Units)
Figure 35. Middle East & Africa Binge Eating Disorder Drug Revenue 2019-2024 ($ Millions)
Figure 36. Americas Binge Eating Disorder Drug Sales Market Share by Country in 2023
Figure 37. Americas Binge Eating Disorder Drug Revenue Market Share by Country in 2023
Figure 38. Americas Binge Eating Disorder Drug Sales Market Share by Type (2019-2024)
Figure 39. Americas Binge Eating Disorder Drug Sales Market Share by Application (2019-2024)
Figure 40. United States Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Binge Eating Disorder Drug Sales Market Share by Region in 2023
Figure 45. APAC Binge Eating Disorder Drug Revenue Market Share by Regions in 2023
Figure 46. APAC Binge Eating Disorder Drug Sales Market Share by Type (2019-2024)
Figure 47. APAC Binge Eating Disorder Drug Sales Market Share by Application (2019-2024)
Figure 48. China Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Binge Eating Disorder Drug Sales Market Share by Country in 2023
Figure 56. Europe Binge Eating Disorder Drug Revenue Market Share by Country in 2023
Figure 57. Europe Binge Eating Disorder Drug Sales Market Share by Type (2019-2024)
Figure 58. Europe Binge Eating Disorder Drug Sales Market Share by Application (2019-2024)
Figure 59. Germany Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Binge Eating Disorder Drug Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Binge Eating Disorder Drug Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Binge Eating Disorder Drug Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Binge Eating Disorder Drug Sales Market Share by Application (2019-2024)
Figure 68. Egypt Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Binge Eating Disorder Drug Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Binge Eating Disorder Drug in 2023
Figure 74. Manufacturing Process Analysis of Binge Eating Disorder Drug
Figure 75. Industry Chain Structure of Binge Eating Disorder Drug
Figure 76. Channels of Distribution
Figure 77. Global Binge Eating Disorder Drug Sales Market Forecast by Region (2025-2030)
Figure 78. Global Binge Eating Disorder Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Binge Eating Disorder Drug Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Binge Eating Disorder Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Binge Eating Disorder Drug Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Binge Eating Disorder Drug Revenue Market Share Forecast by Application (2025-2030)
